Videnskabelige publikationer

  1. Bukh JD et al. At the Core of Depression – A diagnostic interview of the core features of depression (the CORE-DI). Psychopathology 2022;55:219-225
  2. Kessing LV, Bukh JD. The clinical relevance of qualitatively distinct subtypes of depression. World Psychiatry 2017;16:318-319
  3. Kessing LV, Willer I, Andersen PK, Bukh JD. Rate and predictors of conversion from unipolar to bipolar disorder: A systematic review and meta-analysis. Bipolar Disord. 2017;19:324-335.
  4. Suppli NP, Bukh JD, Moffitt TE, Caspi A, Johansen C, Tjønneland A, Kessing LV, Dalton SO. Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis. Depress Anxiety. 2017;34:845-855.
  5. Bukh JD, Andersen PK, Kessing LV. Diagnostic stability of comorbid personality disorders among patients fully or partially remitted from first episode depression - a 5-year follow-up study. J Pers Disord 2017;31:208-220.
  6. Bukh JD, Andersen PK, Kessing LV. Rates and predictors of remission, recurrence and conversion to bipolar disorder after the first lifetime episode of depression - a prospective 5-year follow-up study. Psychol Med 2016;46:1151-61.
  7. Bukh JD, Andersen PK, Kessing LV. Personality and the long-term outcome of first episode depression. A prospective 5 year follow-up study. J Clin Psychiatry 2016;77:e704-10.
  8. Bech P, Kessing LV, Bukh JD. The validity of dysthymia to predict clinical depressive symptoms as measured by the Hamilton Depression Scale at the 5-year follow-up of patients with first episode depression. Nord J Psychiatry. 2016;70:563-6.
  9. Suppli NP, Bukh JD, Moffitt TE, Caspi A, Johansen C, Albieri V, Tjønneland A, Kessing LV, Dalton SO. 5-HTTLPR and use of antidepressants after colorectal cancer including a meta-analysis of 5-HTTLPR and depression after cancer. Translational Psychiatry 2015;5, e631.
  10. Moeller SB, Bech P, Kessing LV, Mortensen EL, Austin SF, Bukh JD. A Psychometric Validation Analysis of Eysenck’s Neuroticism and Extraversion Scales in a Sample of First Time Depressed Patients, J Depress Anxiety 2015; doi: 10.4200/2167-1044.1000202.
  11. Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, Kessing LV. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmachology 2014;39:1399-408.
  12. Bukh JD, Bock C, Kessing LV. Associations between genetic polymorphisms in the serotonergic system and comorbid personality disorders among patients with first episode depression. J Personality Disord 2014;28:365-78.
  13. Kessing LV, Bukh JD. [Depression.]. Ugeskr Laeger 2014;176:1470-73.
  14. Vinberg M, Bukh JD, Kessing LV. Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression? Psychiatry Research 2013;210:102-8.
  15. Bukh JD, Bock C, Vinberg M, Kessing LV. The effect of prolonged duration of untreated depression on antidepressant treatment outcome. J Affect Disord 2013;145: 42-48.
  16. Kessing LV, Bukh JD. [Genetics and stressful life events interact in depression.]. Ugeskr Laeger 2013;175:948-951.
  17. Kessing LV, Bukh JD. [Amitriptyline versus placebo for major depression]. Ugeskr Laeger 2013;175:1875-1877.
  18. Haastrup E, Bukh JD, Bock C et al. Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events. J Affect Disord 2012;136:134-8.
  19. Koefoed P, Woldbye D, Hansen TO, Eplov L, Christiansen SH, Mors O, Kessing LV, Werge T, Kaipio K, Pesonen U, Fahmy T, Mellerup E, Jakobsen KD, Hansen ES, Knudsen GM, Bukh JD, Bock C, Lindberg C, Kristensen AS, Dam H, Nordentoft M, Als TD, Wang AG, Gether U, Rehfeld JF, Bolwig TG. Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression. Acta Neuropsychiatrica 2012;24:81–90.
  20. Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV. Differences between early and late onset adult depression. Clin Pract Epidemiol Ment Health 2011;7:140-7.
  21. Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV. Clinical utility of Standardised Assessment of Personality - Abbreviated Scale (SAPAS) among patients with first episode depression. J Affect Disord 2010;127:199-202.
  22. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur Neuropsychopharmacol 2010;20:327-35.
  23. Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV. Gender differences among patients with a single depressive episode. Psychopathology 2010;43:159-69.
  24. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression. Psychopathology 2010;43:197-204.
  25. Kessing LV, Bukh JD, Bock C, Vinberg M, Gether U. Does bereavement-related first episode depression differ from other kinds of first depressions?. Soc Psychiatry Psychiatr Epidemiol 2010;45:801-8.
  26. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel KL. Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 2009;119:107-15.
  27. Bukh JD, Jorgensen MB, Dam H, Plenge P. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting. Nord J Psychiatry 2009;63:347-51.
  28. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Do stressful life events predict medical treatment outcome in first episode of depression? Soc Psychiatry Psychiatr Epidemiol 2009;44:752-60.
  29. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 2009;5:4.
  30. Secher A, Bukh JD, Bock C et al. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. Int Clin Psychopharmacol 2009;24:199-20.
  31. Bukh JD, Bock C, Mors NP, Kessing LV. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors]. Ugeskr Laeger 2007;169:1439-41.